13F filer · CIK 1103804 ↗
Viking Global
You are looking at Q1 2020. See the latest, Q2 2026 →
Reported value
$19.21B
−10% on the quarter before
Positions
64
21 new · 23 sold out
Top 10
48.4%
of the value
Est. gain
−$1.29B
on stocks held all quarter
Est. return
−9.7%
on those stocks since Q4 2019
Positions as of Mar 31, 2020, from Viking Global's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
Each tile is a position, sized by its share, colored by what the fund did with it since Q4 2019. Striped tiles are options.
Largest buys
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Comcast Corp New~$605.5MAdded · 0.1% → 3.2%+17,612,726 shares
- Microsoft~$556.8MAdded · 1.0% → 4.0%+3,530,518 shares
- Boston Scientific Corp~$434.8MAdded · 3.9% → 5.4%+13,324,535 shares
- Fidelity Natl Information Sv~$394.7MAdded · 0.4% → 2.4%+3,244,748 shares
- Cigna Corp New~$370.4MAdded · 0.4% → 2.3%+2,090,750 shares
- Jpmorgan Chase & Co~$367.8MNew · 0.0% → 1.9%+4,085,317 shares
- American Express Co~$332.0MNew · 0.0% → 1.7%+3,878,280 shares
- Workday~$320.6MNew · 0.0% → 1.7%+2,461,978 shares
- Centene Corp Del~$316.3MAdded · 3.2% → 5.0%+5,323,440 shares
- Alphabet~$299.7MAdded · 0.3% → 1.9%+257,894 shares
Largest sells
Since Q4 2019, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Monster Beverage Corp New~$822.6MSold out · 3.9% → 0.0%−12,944,911 shares
- Meta~$726.3MCut · 6.1% → 1.7%−4,354,449 shares
- Block~$628.4MSold out · 2.9% → 0.0%−10,044,042 shares
- ServiceNow~$597.5MCut · 3.6% → 1.0%−2,085,075 shares
- Metlife Inc~$342.7MSold out · 1.6% → 0.0%−6,723,542 shares
- Uber~$331.3MCut · 5.3% → 3.8%−11,865,797 shares
- Netflix~$328.0MCut · 5.4% → 5.2%−873,391 shares
- Anthem Inc~$289.6MCut · 4.4% → 2.1%−1,275,567 shares
- Unitedhealth Group Inc~$281.6MSold out · 1.3% → 0.0%−958,037 shares
- Activision Blizzard Inc~$239.1MSold out · 1.1% → 0.0%−4,023,395 shares
Holdings
As of Mar 31, 2020. Changes are in shares against Dec 31, 2019, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AmazonCOM · shares −1.1% · price +5.5% | 8.9% | $1.72B | +$89.7M | ||||||||
| Boston Scientific CorpCOM · shares +72% · price −27.8% | 5.4% | $1.04B | −$232.8M | ||||||||
| NetflixCOM · shares −25% · price +16.0% | 5.2% | $998.5M | +$138.1M | ||||||||
| Centene Corp DelCOM · shares +49% · price −5.5% | 5.0% | $964.3M | −$37.7M | ||||||||
| Adaptive Biotechnologies CorCOM · shares −13% · price −7.2% | 4.8% | $930.5M | −$71.7M | ||||||||
| MicrosoftCOM · shares +258% · price +0.0% | 4.0% | $772.8M | +$13,227 | ||||||||
| Bridgebio Pharma IncCOM · shares 0% · price −17.3% | 4.0% | $772.0M | −$161.1M | ||||||||
| Jd Com IncSPON ADR CL A · shares −15% · price +15.0% | 4.0% | $763.8M | +$99.4M | ||||||||
| UberCOM · shares −31% · price −6.1% | 3.8% | $732.2M | −$47.7M | ||||||||
| Comcast Corp NewCL A · shares +6,072% · price −23.5% | 3.2% | $615.5M | −$3.1M | ||||||||
| Fortive CorpCOM · shares +31% · price −27.8% | 2.7% | $519.7M | −$151.9M | ||||||||
| SalesforceCOM · shares −20% · price −11.5% | 2.6% | $504.9M | −$65.4M | ||||||||
| Lowes Cos IncCOM · shares +24% · price −28.1% | 2.5% | $470.7M | −$149.1M | ||||||||
| Fidelity Natl Information SvCOM · shares +585% · price −12.5% | 2.4% | $462.2M | −$9.7M | ||||||||
| Cigna Corp NewCOM · shares +457% · price −13.4% | 2.3% | $451.4M | −$12.5M | ||||||||
| Anthem IncCOM · shares −41% · price −24.8% | 2.1% | $411.1M | −$135.8M | ||||||||
| Aon PlcSHS CL A · shares +197% · price −20.8% | 2.0% | $378.0M | −$33.4M | ||||||||
| Jpmorgan Chase & CoCOM · shares New | 1.9% | $367.8M | — | ||||||||
| AlphabetCAP STK CL A · shares +466% · price −13.2% | 1.9% | $363.9M | −$9.8M | ||||||||
| MetaCL A · shares −68% · price −18.7% | 1.7% | $335.1M | −$77.3M | ||||||||
| American Express CoCOM · shares New | 1.7% | $332.0M | — | ||||||||
| WorkdayCL A · shares New | 1.7% | $320.6M | — | ||||||||
| Ingersoll Rand IncCOM · shares New | 1.6% | $297.9M | — | ||||||||
| Cme Group IncCOM · shares New | 1.5% | $294.3M | — | ||||||||
| MicronCOM · shares New | 1.5% | $282.3M | — | ||||||||
| Total · 64 positions | 100% | $19.21B | −$1.29B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q4 2019 to Q1 2020: 43 stocks held throughout, down $1.29B (−9.7%).
- Netflix+$138.1M+16%
- Jd Com Inc+$99.4M+15%
- Amazon+$89.7M+6%
- Bristol-Myers Squibb Co+$15.5M+26%
- Viela Bio Inc+$13.6M+40%
- Anthem Inc−$135.8M−25%
- Lowes Cos Inc−$149.1M−28%
- Fortive Corp−$151.9M−28%
- Bridgebio Pharma Inc−$161.1M−17%
- Boston Scientific Corp−$232.8M−28%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 14, 2026 | $35.08B−2% | SEC ↗ |
| Q1 2026 | May 15, 2026 | $35.75B−5% | SEC ↗ |
| Q4 2025 | Feb 17, 2026 | $37.68B−2% | SEC ↗ |
| Q3 2025 | Nov 14, 2025 | $38.50B+11% | SEC ↗ |
| Q2 2025 | Aug 14, 2025 | $34.59B+10% | SEC ↗ |
| Q1 2025 | May 15, 2025 | $31.48B+2% | SEC ↗ |
| Q4 2024 | Feb 14, 2025 | $30.90B+13% | SEC ↗ |
| Q3 2024 | Nov 14, 2024 | $27.44B+5% | SEC ↗ |
| Q2 2024 | Aug 14, 2024 | $26.02B−3% | SEC ↗ |
| Q1 2024 | May 15, 2024 | $26.86B−2% | SEC ↗ |
| Q4 2023 | Feb 14, 2024 | $27.30B+11% | SEC ↗ |
| Q3 2023 | Nov 14, 2023 | $24.64B+1% | SEC ↗ |
| Q2 2023 | Aug 14, 2023 | $24.43B+15% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $21.31B+7% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $19.98B−8% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $21.66B−1% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $21.86B−12% | SEC ↗ |
| Q1 2022 | May 16, 2022 | $24.74B−29% | SEC ↗ |
| Q4 2021 | May 16, 2022 (amended) | $34.71B−5% | SEC ↗ |
| Q3 2021 | May 16, 2022 (amended) | $36.46B+11% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $32.98B−2% | SEC ↗ |
| Q1 2021 | May 17, 2021 | $33.58B−8% | SEC ↗ |
| Q4 2020 | Feb 16, 2021 | $36.37B+31% | SEC ↗ |
| Q3 2020 | Nov 16, 2020 | $27.68B+20% | SEC ↗ |
| Q2 2020 | Aug 7, 2020 | $23.14B+20% | SEC ↗ |
| Q1 2020 | May 13, 2020 | $19.21B−10% | SEC ↗ |
| Q4 2019 | Feb 13, 2020 | $21.35B+11% | SEC ↗ |
| Q3 2019 | Nov 13, 2019 | $19.20B−14% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $22.29B+28% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $17.44B−1% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $17.57B−3% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $18.06B+3% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $17.47B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $16.61B+2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $16.26B+5% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $15.44B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $14.85B−34% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $22.64B+3% | SEC ↗ |
| Q4 2016 | Feb 14, 2017 | $22.01B−5% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $23.18B−2% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $23.54B+4% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $22.72B | SEC ↗ |